Endotoxin initiates the systemic inflammatory response, haemodynamic changes, and multi-organ failure that may occur as a consequence of systemic
gram-negative bacterial infection. The
serum protein lipopolysaccharide-binding protein (LBP) binds to the
lipid A component of bacterial
endotoxin and facilitates its delivery to the
CD14 antigen on the macrophage, where inflammatory
cytokines are released and a cascade of host mediators is initiated. The neutrophil granular
protein bactericidal/permeability-increasing protein (BPI) competes with LBP for
endotoxin binding and functions as a molecular antagonist of LBP-
endotoxin interactions. We have measured concentrations of both
proteins in body fluids from 49 consecutive patients. In 16 of 17 samples of fluid from closed-space
infections, BPI was present in greater concentration than LBP (median BPI/LBP ratio 7.6 [95% CI 2.32-22.1]). The ratio of BPI and LBP was not significantly different from 1.0 in abdominal fluid from 10 patients with
peritonitis (ratio 0.235 [0.18-0.47]), whereas the BPI/LBP ratio was low in 22 non-infected body fluids (0.01 [0.001-0.04]) and concentrations of both
proteins approached those in normal human plasma. BPI concentrations were directly correlated with the quantity of neutrophils within clinical samples (rs = 0.81, p < 0.0001). Thus, within
abscess cavities BPI is available in sufficient quantities for effective competition with LBP for
endotoxin. BPI may attenuate the local inflammatory response and the systemic toxicity of
endotoxin release during gram-negative
infections.